Literature DB >> 8278637

Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene?

A D Steinberg1, J M DeSesso.   

Abstract

Trichloroethylene (TCE) is widely viewed as an environmental hazard. Its major metabolite, chloral hydrate, is a currently used medicine. Regulation of TCE is based on a linear extrapolation from effects of high doses in rodents to risks for humans at low doses. However, metabolic, toxicologic, and epidemiologic data on trichloroethylene and chloral hydrate as well as water chlorination studies call this approach into question. The mechanism of carcinogenesis of TCE and chloral hydrate in rodents is nonlinear: very high doses, sufficient to cause cellular necrosis, are necessary. Malignancy arises from repeated cycles of necrosis and regeneration with the ultimate emergence of hyperplasia and then neoplasia. Metabolites of TCE, trichloroacetic acid and dichloroacetic acid, mediate this toxic effect of TCE. These chloroacetic acids also induce similar lesions in rodents given high doses of the medicine, chloral hydrate. Human epidemiologic data show no increase in mortality or malignancy from substantial chronic exposure to trichloroethylene. Chlorination of drinking water produces much higher levels of chloroacetic acids than could be obtained from metabolizing TCE under current regulations. We conclude that the assumptions underlying current regulations are not applicable to TCE. Instead of a straight-line extrapolation model, a threshold model may be more appropriate. The data suggest that it is possible to increase substantially the allowable trichloroethylene in drinking water without increasing health hazards.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8278637     DOI: 10.1006/rtph.1993.1049

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  7 in total

1.  Short-term chloral hydrate administration and cancer in humans.

Authors:  Tmirah Haselkorn; Alice S Whittemore; Natalia Udaltsova; Gary D Friedman
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Gene expression profiling in the fetal cardiac tissue after folate and low-dose trichloroethylene exposure.

Authors:  Patricia T Caldwell; Ann Manziello; Jamie Howard; Brittany Palbykin; Raymond B Runyan; Ornella Selmin
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-02

3.  Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. II. 1,1,1-Trichloroethane and trichloroethylene.

Authors:  S Laparé; R Tardif; J Brodeur
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

4.  Threshold of trichloroethylene contamination in maternal drinking waters affecting fetal heart development in the rat.

Authors:  Paula D Johnson; Stanley J Goldberg; Mary Z Mays; Brenda V Dawson
Journal:  Environ Health Perspect       Date:  2003-03       Impact factor: 9.031

Review 5.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

6.  Multigenerational study of chemically induced cytotoxicity and proliferation in cultures of human proximal tubular cells.

Authors:  Lawrence H Lash; David A Putt; Bavneet Benipal
Journal:  Int J Mol Sci       Date:  2014-11-18       Impact factor: 5.923

Review 7.  A review: trichloroethylene metabolites: potential cardiac teratogens.

Authors:  P D Johnson; B V Dawson; S J Goldberg
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.